The problem of sudden cardiac death (SCD) from ventricular fibrillation (VF) during coronary artery occlusion or reperfusion, outside the hospital setting, is still the biggest challenge that clinical cardiology faces. More than half of SCDs can be attributed to sudden VF. As drug therapy has proved to be largely ineffective except in the hospital setting, understanding the underlying mechanisms that lead to these life-threatening ventricular arrhythmias is crucial for developing novel therapeutic strategies.Several experimental models -from cells to in situ animal models -are available for exploring the dynamic changes during the acute phase of myocardial ischemia that are responsible for the occurrence of the accompanying severe, often fatal, ventricular arrhythmias. The dynamic nature of ischemia development can be discussed by considering its several aspects. With respect to associated arrhythmias, four phases of the ischemic events are distinguished within the first hour. The sequence of these changes is time-dependent. Studies in large animals showed that after commencement of occlusion, the rapidly developing and progressing ischemic changes give rise to an early phase of arrhythmias (phase 1A) which, in anesthetized dogs, is apparent between 3 and 8 min of start of ischemia [1]. This is followed by a restoration of normal rhythm (compensatory phase) during which the ionic changes become balanced, and electrophysiological parameters seem to return to normal [2]. This phase might be of particular importance as changes during this short (5 min) period directly contribute to the next event (phase 1B) of arrhythmias. Phase 1B lasts from 15 to 30 min of ischemia and is more severe than phase 1A arrhythmias, often terminating in sudden VF [3,4]. After this period, if ischemia is maintained, a "healing over" process starts during which the dying cells are sharply demarcated from the viable ones by interrupting the electrical and metabolic